Navigation Links
Feinstein Institute to Receive $330,000 Grant to Support Research of Childhood Cancer
Date:9/19/2013

Manhasset, NY (PRWEB) September 19, 2013

The Feinstein Institute for Medical Research announced today it will receive $330,000 in grants aimed at gaining a better understanding of a pediatric cancer syndrome called Diamond Blackfan anemia. The grants were awarded by the St. Baldrick’s Foundation, a volunteer-driven and donor-centered charity dedicated to raising money for childhood cancer research. It will support the work of a Feinstein Institute physician-researcher and consortium.

Sharon Singh, MD, will receive $230,000 to support her research project focused on Diamond Blackfan anemia. Diamond Blackfan anemia is an inherited condition that leads to anemia, possible birth defects and cancer. Dr. Singh’s team is working to understand the conditions that promote the formation and survival of cancer cells in this syndrome, to improve early diagnosis and treatment of childhood cancer.

“I am very thankful to receive this grant as it will support me in working to identify what conditions may lead to the development of cancer in children,” said Dr. Singh. “If my colleagues and I can identify why certain children develop cancer while others do not, we may be able to prevent future children from suffering from cancer.”

The Pediatric Myelodysplastic Syndromes and Ribosome Dysfunction Consortium at the Feinstein Institute, led by Johnson Liu, MD, will receive $100,000 to support ongoing work. The consortium is focused on a group of childhood disorders including Diamond-Blackfan anemia. Specifically, the researchers who comprise the consortium are exploring different ways they can manage Diamond-Blackfan anemia once a patient is diagnosed with it so that it doesn’t lead to anemia and cancer.

“The Pediatric Myelodysplastic Syndromes and Ribosome Dysfunction Consortium is a very unique group – I don’t know of another group in the world that has the concerted effort and capability to study Diamond Blackfan anemia or pre-leukemia in children,” said Dr. Liu. “The support by the St. Baldrick’s Foundation will enable us to continue and expand our research and hopefully identify new ways to manage or treat this deadly disease.”

About The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit http://www.FeinsteinInstitute.org.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11131404.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. North Shore-LIJ Health System's Feinstein Institute to Receive $250,000 Grant from Lymphoma Research Foundation Grant to support research of Chronic Lymphocytic Leukemia
2. Summer Benefit Concert Raised More Than $1.5 Million for Feinstein Institute
3. Long Island Bike Challenge Rides to Raise Money for North Shore-LIJ's Feinstein Institute of Medical Research
4. Feinstein Institute, Hofstra North Shore-LIJ School of Medicine at 36th Annual Conference on Shock
5. North Shore-LIJ's Feinstein Institute Hosts Academic Commencement and Convocation
6. North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week
7. Feinstein Institute Researcher provides insight into osteoarthritis
8. Feinstein Institute Scientist Wins Crafoord Award from Royal Swedish Academy of Sciences for Arthritis Research
9. A Feinstein Institute for Medical Research Study Shows Early Cognitive Problems among Those Who Eventually Get Alzheimer's
10. Feinstein Institute researchers discover plant derivative
11. Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health ... Miles by Moonlight to raise money for the American Heart Association Heart Walk. Teams ... Teams will work together to keep their treadmills moving for 5 hours. Treadmills will ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... ... presenting the latest in wound care advancements to physician colleagues, skilled nursing facility ... is titled, "Navigating the Treacherous Waters of Wound Care." , "At many of ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
Breaking Medicine Technology: